Rossi, J., Ashraf, A., Kelahmetoglu, Y., Fajgenbaum, D., Shyamsundar, S., Rhee, F. V. (2025). Siltuximab-mediated suppression of CRP is associated with clinical response in idiopathic multicentric castleman disease. Blood. https://doi.org/10.1182/blood-2025-4788